Michael T. McCaul
Tickers in This Filing
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsMichael T. McCaul bought $1,000,001-$5,000,000 in $FDX on 2025-07-24, 8 days before S2677, a bill expanding information sharing on intellectual property violations, which could benefit brands by increasing enforcement against counterfeit goods.
Michael T. McCaul bought $1,000,001-$5,000,000 in $ABT on 2025-07-21, 45 days before HR5127, a bill mandating no-cost coverage for HIV prevention drugs and services, which could increase demand for related medical products.
Michael T. McCaul bought $1,000,001-$5,000,000 in $ABT on 2025-07-21, 58 days before HR5343, a bill that advanced out of committee, indicating significant legislative momentum for ensuring patient access to critical breakthrough products.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Other | LLM FAMILY INVESTMENTS LP(Other) | $1,000,001-$5,000,000 | — | — | — | Jul 7, 2025 |
| BUY | Mutual Fund | Artisan High Income Fund Institutional Shares(Mutual Fund) | $1,000,001-$5,000,000 | — | — | — | Jul 29, 2025 |
| BUY | Other | Dawson Portfolio Finance 6 LP(Other) | $1,000,001-$5,000,000 | — | — | — | Jul 24, 2025 |
| BUY | Other | Levine Leichtman Capital Partners VII LP(Other) | $1,000,001-$5,000,000 | — | — | — | Jul 17, 2025 |
| BUY | Municipal Bond | NEW JERSEY ST HEA STUD(Municipal Bond) | $1,000,001-$5,000,000 | — | — | — | Jul 11, 2025 |
| BUY | $MSFT | MICROSOFT CORP | $1,000,001-$5,000,000 | $511.70 | $422.58 | -17.4% | Jul 17, 2025 |
| BUY | Municipal Bond | ROGERS ARK SALES & USE(Municipal Bond) | $1,000,001-$5,000,000 | — | — | — | Jul 24, 2025 |
| BUY | Municipal Bond | TRIBOROUGH BRDG & TUNL(Municipal Bond) | $1,000,001-$5,000,000 | — | — | — | Jul 24, 2025 |
| BUY | Municipal Bond | KANSAS ST DEV FIN AUTH(Municipal Bond) | $1,000,001-$5,000,000 | — | — | — | Jul 30, 2025 |
| BUY | Municipal Bond | RICHARDSON TEX INDPT SCH(Municipal Bond) | $1,000,001-$5,000,000 | — | — | — | Jul 21, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PrEP and PEP are Prevention Act
The PrEP and PEP are Prevention Act (HR5127) mandates zero-cost coverage of HIV prevention drugs and associated lab monitoring across all US insurance programs. This early-stage bipartisan bill creates direct volume upside for Gilead ($GILD) on branded PrEP, Viatris ($VTRS) on generic PrEP, and Labcorp ($LH) on mandatory diagnostic services. Merck ($MRK) is excluded from the causal chain because its islatravir candidate is not FDA-approved and the bill only covers approved drugs.
Streamlining Rural Housing Act of 2025
HR4989 (Streamlining Rural Housing Act) is in early-stage committee referral with zero chance of near-term market impact. The bill requires HUD and USDA to negotiate an MOU on environmental review processes, authorizing no spending. Homebuilder and bank tickers are structurally exposed to a future regulatory easing but show no evidence of current revenue benefit. The real market data shows a broad homebuilder sell-off over the past 7 days (-5.8% to -7.6%) driven by macro factors, not this dormant legislation.
Proposing a balanced budget amendment to the Constitution of the United States.
H.J. Res. 110 is a procedural introduction of a balanced budget constitutional amendment with zero near-term market impact. The bill was referred to the House Judiciary Committee on July 23, 2025, and has had no further action. No committee hearings, no companion Senate bill, and no mechanism to allocate or appropriate any funds exist. Retail investors should ignore this bill as a market signal.
Unclaimed Retirement Rescue Plan
H.R. 5325 is an early-stage, bipartisan bill from September 2025 that would allow voluntary transfer of unclaimed retirement distributions to state unclaimed property programs. It creates no new revenue, spending, or liabilities — market impact is minimal to zero. The bill remains in committee with no further action in over seven months, making it legislative noise for retail investors.
MAPWaters Act of 2025
The MAPWaters Act, with a companion bill already signed into law (HR187 → PL 119-62), mandates federal agencies to standardize geospatial waterway data. Trimble ($TRMB) is the primary pure-play beneficiary. The stock is at $66.84, near the bottom of its 52-week range ($62–$87.5), offering a potential entry point if procurement contracts materialize. No funding is authorized directly, so revenue depends on agency procurement budgets.
AI Accountability and Personal Data Protection Act
S.2367 introduces a broad federal tort for personal data exploitation without express consent, directly targeting the data practices underlying AI training and advertising at META, GOOGL, AMZN, MSFT, and CRM. The bill is early-stage (introduced July 2025, referred to Judiciary Committee), but its language is aggressive and unambiguous. Current market prices show a sharp 1-day drop for META (-8.72% 7-day) and GOOGL at an all-time high of $373.96 — divergence suggests GOOGL's run is driven by other factors, not immunity from this risk.
Blue Shield Privacy Act of 2025
The Blue Shield Privacy Act of 2025 (HR4828) is an early-stage House bill that expands the definition of 'restricted personal information' under federal criminal law to include biometric data, GPS coordinates, license plates, and workplace/school addresses. At referral to the House Judiciary Committee only, with 7 cosponsors and no markup or hearings yet, the bill has no near-term market impact. Real market data show GOOGL at $368.29 (up 6.94% over 7 days, up 28.07% over 30 days), META at $600.42 (down 11.05% over 7 days), AMZN at $258.48 (down 2.09% over 7 days), and MSFT at $400.59 (down 5.66% over 7 days) — these price movements are driven by other factors, not this procedural bill.
A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
S.2677 is an early-stage procedural bill that expands CBP's authority to share IP violation data with rights holders. It imposes minimal compliance obligations on marketplaces and carriers but has zero appropriated funding. This bill has no material market-moving potential for any company. Retail investors should ignore this legislation for trading decisions.
Ensuring Patient Access to Critical Breakthrough Products Act
HR5343 would force Medicare to provide immediate 4-year coverage for FDA breakthrough devices, directly benefiting large medical device manufacturers by eliminating the current 1-3 year coverage lag. The bill passed the Ways & Means committee 37-3 but awaits floor action. Despite bearish recent price action (MDT -8.2%, ABT -11%, BDX -7.3% in 30 days), this bill represents a structural catalyst for device revenue acceleration.
Stop Chinese Fentanyl Act of 2025
HR747 (Stop Chinese Fentanyl Act) is an early-stage House bill expanding sanctions definitions for Chinese entities involved in opioid precursors. The bill has been reported by committee but faces a long legislative path. Market data shows chemicals ($DD, $ECL) are near 30-day lows while logistics ($UPS, $FDX, $CHRW) have rallied 12-15% in the last month, indicating no market pricing of this bill's risk. Impact score is low at 2 because the bill authorizes zero funding, remains early-stage, and would affect a narrow subset of US-China chemical trade.
Other Filings by Michael T. McCaul
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.